Fundraising Fox
Spiral Therapeutics
South San Francisco, US · Founded 2016 · Delaware corporation · 11 known investors
Find your way into Spiral Therapeutics
Sign up to see every warm intro you have to Spiral Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Spiral Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Spiral Therapeutics is a clinical-stage pharmaceutical company developing therapies for balance disorders and hearing loss using its Minimally Invasive Cochlear System (MICS) drug delivery platform. Its lead program, SPT-2101, is a sustained-release dexamethasone formulation for treating Ménière's disease.
Founders & leadership
Spiral Therapeutics was founded in 2016 by Hugo Peris.
Board
Investors · 11
How we know: the company's own site · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: StartX's portfolio page · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: a partner's Signal profile · press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Also in the syndicate · 4
Reported raises · per SEC filings
Form D private placements$46.5M disclosed across 3 rounds · 2018–2025
▶$27.1MraisedApr 2026 · 34 investors · PharmaceuticalsRule 506(b)
- WARREN THALERDirector
- EUGENE DE JUANExecutive Officer, Director
- ANTHONY ADAMISDirector
- FREDERIC GUERARDDirector
- JEAN-FREDERIC PAULSENDirector
- GUY JEAN SAVOIR GARCIADirector
- HUGO PERISExecutive Officer, Director
- DIAMANTIS XYLASDirector
- ANGELA MACFARLANEDirector
- Offering amount
- $27.1M
- Amount sold
- $27.1M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.9MraisedFeb 2023 · 48 investors · Other Health CareRule 506(b)
- EUGENE DE JUANDirector
- GUY P. NOHRADirector
- ANGELA MACFARLANEDirector
- GUY JEAN SAVOIR GARCIADirector
- ANTHONY ADAMISDirector
- HUGO PERISExecutive Officer, Director
- DIAMANTIS XYLASDirector
- Offering amount
- $10.9M
- Amount sold
- $10.9M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.5MraisedDec 2018 · 38 investors · Other Health CareRule 506(b)
- Eugene de JuanDirector
- Guy Jean Savoir GarciaDirector
- Hugo PerisExecutive Officer, Director
- Guy NohraDirector
- Lawrence FritzDirector
- Offering amount
- $12.9M
- Amount sold
- $8.5M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Spiral Therapeutics went on to found or lead other companies.
In the news
Frequently asked questions
- What does Spiral Therapeutics do?
- Spiral Therapeutics is a clinical-stage pharmaceutical company developing therapies for balance disorders and hearing loss using its Minimally Invasive Cochlear System (MICS) drug delivery platform. Its lead program, SPT-2101, is a sustained-release dexamethasone formulation for treating Ménière's disease.
- Who founded Spiral Therapeutics?
- Spiral Therapeutics was founded by Hugo Peris in 2016.
- Who are Spiral Therapeutics's investors?
- Spiral Therapeutics's investors include Catalio Capital Management, Inveready Technology Investment Group, Lifelink, StartX, Alta Partners, Camden Partners, Esperante Ventures.
- How much funding has Spiral Therapeutics raised?
- Spiral Therapeutics has disclosed $46.5M raised across 3 rounds.
- Where is Spiral Therapeutics headquartered?
- Spiral Therapeutics is headquartered in South San Francisco, US.